High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors

Yago Nieto(The University of Texas MD Anderson Cancer Center), Matthew T. Campbell(The University of Texas MD Anderson Cancer Center), Shi‐Ming Tu(The University of Texas MD Anderson Cancer Center), Andrew Johns(University Hospitals Sussex NHS Foundation Trust), Irtiza Sheikh(The University of Texas MD Anderson Cancer Center), Muzaffar H. Qazilbash(The University of Texas MD Anderson Cancer Center), Amishi Y. Shah(The University of Texas MD Anderson Cancer Center), Jeremy Ramdial(The University of Texas MD Anderson Cancer Center), Roland L. Bassett(The University of Texas MD Anderson Cancer Center), Terri Lynn Shigle(The University of Texas MD Anderson Cancer Center), John K. Lin(Harvard Global Health Institute), Ala Abudayyeh(The University of Texas MD Anderson Cancer Center), Louis L. Pisters(The University of Texas MD Anderson Cancer Center), John C. Araujo(The University of Texas MD Anderson Cancer Center), John F. Ward(The University of Texas MD Anderson Cancer Center), Elizabeth J. Shpall(Scripps MD Anderson Cancer Center), Alison Gulbis(The University of Texas MD Anderson Cancer Center), Uday Popat(The University of Texas MD Anderson Cancer Center), J. Li(The University of Texas MD Anderson Cancer Center), José A. Karam(The University of Texas MD Anderson Cancer Center), Lance C. Pagliaro(The University of Texas MD Anderson Cancer Center), David C. Rice(The University of Texas MD Anderson Cancer Center), Jean‐Nicolas Vauthey(The University of Texas MD Anderson Cancer Center), M. J. Barnett(The University of Texas MD Anderson Cancer Center), Roy B. Jones(The University of Texas MD Anderson Cancer Center), Peter F. Thall(The University of Texas MD Anderson Cancer Center), Wayne L. Hofstetter(The University of Texas MD Anderson Cancer Center), Börje S. Andersson(The University of Texas MD Anderson Cancer Center)
Clinical Cancer Research
August 25, 2025
10.1158/1078-0432.ccr-25-1917
Cited by 2

Related Papers

National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants
|The Lancet|2011|4.1k
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
|The Lancet|2011|3.6k
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k
Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery
|Surgery|2011|1.9k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k